NEXGEL, INC. Files 8-K: Agreements, Equity Sales, Officer Changes
Ticker: NXGLW · Form: 8-K · Filed: Jan 6, 2025 · CIK: 1468929
| Field | Detail |
|---|---|
| Company | Nexgel, Inc. (NXGLW) |
| Form Type | 8-K |
| Filed Date | Jan 6, 2025 |
| Risk Level | medium |
| Pages | 10 |
| Reading Time | 13 min |
| Key Dollar Amounts | $0.001, $375,000, $50,000, $100,000, $3.829 |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, equity-sale, officer-changes
Related Tickers: NXGL
TL;DR
NEXGEL filed an 8-K detailing new agreements, equity sales, and exec changes as of Dec 30, 2024.
AI Summary
On December 30, 2024, NEXGEL, INC. entered into a material definitive agreement. The company also reported on unregistered sales of equity securities and changes in its board and officer composition, including compensatory arrangements. The filing also covers other events and financial statements/exhibits.
Why It Matters
This 8-K filing indicates significant corporate activity for NEXGEL, INC., including new agreements and potential equity dilution, which could impact investors.
Risk Assessment
Risk Level: medium — The filing mentions unregistered sales of equity securities and changes in officers, which can introduce uncertainty and potential dilution.
Key Players & Entities
- NEXGEL, INC. (company) — Registrant
- December 30, 2024 (date) — Date of earliest event reported
FAQ
What type of material definitive agreement did NEXGEL, INC. enter into?
The filing indicates NEXGEL, INC. entered into a material definitive agreement on December 30, 2024, but the specific details of the agreement are not provided in this excerpt.
What are the key items reported in this 8-K filing?
This 8-K filing reports on the entry into a material definitive agreement, unregistered sales of equity securities, departure/election of directors and officers, compensatory arrangements, other events, and financial statements/exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on December 30, 2024.
What is NEXGEL, INC.'s SIC code?
NEXGEL, INC.'s Standard Industrial Classification (SIC) code is 3841, which corresponds to SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.
What was NEXGEL, INC.'s former company name?
NEXGEL, INC.'s former company name was AquaMed Technologies, Inc., with a date of name change on July 23, 2009.
Filing Stats: 3,135 words · 13 min read · ~10 pages · Grade level 11.8 · Accepted 2025-01-06 16:30:34
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 NXGL The Nasdaq Capital Market LLC
- $375,000 — Mr. Levy will be paid a base salary of $375,000 per year, which is an increase of $50,0
- $50,000 — 5,000 per year, which is an increase of $50,000 per year over his current base salary.
- $100,000 — of the Company's common stock equal to $100,000 divided by the closing per share price
- $3.829 — Nasdaq ") on January 2, 2025, which was $3.829 and equates to 26,116 shares of common
- $3 — stock at a per share exercise price of $3.829, which is equal to the closing per
- $25,000 — ses as follows: A cash bonus equal to $25,000 (which was paid on December 31, 2024) a
- $4.50 — ior to March 12, 2025 equals or exceeds $4.50 per share or (but not and) the average
- $5.50 — s of fiscal year 2026 equals or exceeds $5.50 per share or (ii) the Company raises an
- $2,500,000, M — oss proceeds to the Company of at least $2,500,000, Mr. Levy shall receive (i) a cash bonus e
- $7.50 — s of fiscal year 2026 equals or exceeds $7.50 per share or (ii) the Company raises an
- $2,500,000 — oss proceeds to the Company of at least $2,500,000, (i) a cash bonus equal to $50,000 and
- $200,000 — . McGuire will be paid a base salary of $200,000 per year. Also, Mr. McGuire will be eli
Filing Documents
- form8-k.htm (8-K) — 82KB
- ex10-1.htm (EX-10.1) — 80KB
- ex10-2.htm (EX-10.2) — 69KB
- ex99-1.htm (EX-99.1) — 11KB
- 0001493152-25-001000.txt ( ) — 510KB
- nxgl-20241230.xsd (EX-101.SCH) — 4KB
- nxgl-20241230_def.xml (EX-101.DEF) — 29KB
- nxgl-20241230_lab.xml (EX-101.LAB) — 36KB
- nxgl-20241230_pre.xml (EX-101.PRE) — 26KB
- form8-k_htm.xml (XML) — 6KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: January 6, 2025 NEXGEL, INC . By: /s/ Adam Levy Adam Levy Chief Executive Officer